A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma

Peter M. Anderson, Stefan S. Bielack, Richard G. Gorlick, Keith Skubitz, Najat C. Daw, Cynthia E. Herzog, Odd R. Monge, Alvaro Lassaletta, Erica Boldrini, Zsuzanna Pápai, Joseph Rubino, Kumudu Pathiraja, Darcy A. Hille, Mark Ayers, Siu Long Yao, Michael Nebozhyn, Brian Lu, David Mauro